Derm Flashcards

1
Q

Incontinentia Pigmenta

A
  • This is typically lethal in males antenatally.
  • X-linked In most patients, cutaneous manifestations are present at birth or occur within the first 2 weeks of life. The cutaneous manifestations usually appear in a characteristic, chronologic sequence.
  • Other systemic manifestations, including ocular defects, CNS abnormalities, and dental abnormalities, may not be recognised until infancy or early childhood.
  • Diagnostic criteria for incontinentia pigmenti have been proposed. In the absence of a family history, the presence of at least 1 major criterion is necessary. The presence of minor criteria supports the diagnosis of incontinentia pigmenti.

Major criteria are: typical neonatal vesicular rash with eosinophilia -typical blaschkoid hyperpigmentation on the trunk, fading in adolescence -linear, atrophic hairless lesions.

Minor criteria are:

  • -dental anomalies,
  • -alopecia,
  • -wooly hair,
  • -abnormal nails

With a definitive family history, the presence of any major criterion strongly supports the diagnosis of incontinentia pigmenti.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ichthyosis

A

– the ichthyosiform dermatoses are a diverse group of hereditary skin disorders characterised by the accumulation of “fish-like” scales resulting from abnormal epidermal cell kinetics or differentiation.

  • The severity of the individual disorders ranges from asymptomatic to life-threatening.
  • Icthyosis vulgaris – mildest form. Presents during childhood, not apparent in the newborn.
  • X-linked icthyosis – affects males, onset at 2-6 weeks of age, worsens with age. Large brown adherent scales.
  • Lamellar icthyosis – affected patients present as a “collodian baby” at birth.
  • CIE (congenital icthyosiform erythroderma) – also presents as a “collodian baby.”
  • Epidermolytic ichthyosis – also known as bullous ichthyosis or bullous CIE. Presents with widespread blistering and erythema.
  • Harlequin ichthyosis – the most severe form, often lethal perinatally.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SJS/TEN

A

Severe adverse cutaneous drug reaction characterised by mucocutaneous tenderness, erythema & extensive exfoliation

  • SJS <10% BSA detachment
  • SJS-TEN overlap: 10-30% BSA detachment
  • TEN >30% BSA detachment

Most common triggers:

  • NSAIDs
  • Antibiotics: sulfonamides, aminopenicillins, cephalosporins
  • Anticonvulsants: carbamazepine, phenytoin, lamotrigine
  • Checkpoint inhibitors: ipilimumab, nivolumab
  • Allopurinol

Onset symptoms 7-21 days after initiation of drug

Aetiology: • In predisposed individuals, immune response to a drug leads to secretion of cytotoxic granulysin plus interaction of Fas-FasL apoptosis of keratinocytes leads to separation of skin at dermal-epidermal junction

Clinical features:

  • Prodrome:URTIsx, fever,painful skin, pain on swallowing
  • Skin: erythematous–dusky maculesstart on trunk, spread to head/limbs, coalesce casein epidermal detachment
  • Mucosa:erythema,erosions, haemorrhagic crusting

HLA types - Carbamazepime HLA B1502 - Allopurinol HLA b5801

Rx • STOP culprit drug/s

  • Admit ICU with MDT input • Supportive care • Gentle handling, barrier nursing
  • Treat secondary infection
  • Fluid/electrolyte management + nutritional support
  • Skin + mucosal care: dressings, emollients, eye drops • Systemic treatment – controversial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SJS VS TEN VS Erythema multiforme

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Morbilloform drug reaction

A
  • Most common drug causes: penicillins, cephalosporins, sulfonamides, aromatic anticonvulsants, allopurinol
  • Onset typically 7-14 days after initial drug administration
  • Symmetrically distributed erythematous macules and papules trunk and proximal limbs - >confluent erythema
  • No mucous membrane involvement
  • Itch + low-grade fever
  • Resolves without sequelae 1-2 weeks
  • Viral infection + drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

A

DRESS diagnostic criteria
• Maculopapular rash developing > 3 weeks after drug initiation • Prolonged symptoms after discontinuation of causative drug
• Fever
• LFT abnormalities (ALT 100 U/L) or impaired renal function

  • WCC abnormalities:
  • Leukocytosis >11 x 109/L
  • Atypical lymphocytes >5% • Eosinophilia >1.5 x 109/L

• Lymphadenopathy • HHV-6 reactivation

Commonly implicated drugs:

  • Allopurinol
  • Anticonvulsants
  • Antibiotics – trimethoprim- sulfamethoxazole, minocycline, vancomycin, penicillins
  • Antiretrovirals
  • Ibuprofen, aspirin
  • Onset after drug initiation: 2-6 weeks
  • HLA-B*31:01 & carbamazepin

Mx: STOP drug, oral prednisolone tapered over 6-8 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HLA typing associated with risk SJS with Carbamazepine

A

HLA B 1502

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fixed drug eruption

A

Well-defined round-oval erythematous patches -> purple/brown. May blister

Recurs at the same site/s each time drug is administered

• Mucosal & acral sites commonly affected

Onset: 30 minutes to 8 hours after taking drug

Typical agents: paracetamol, tetracyclines, sulfur antibiotics, NSAIDs

Variant: generalised bullous fixed drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Serum sickness-like reaction

A

Clinical features:

  • Fever, arthralgias, arthritis, rash (urticarial, morbilliform), lymphadenopathy
  • Onset 1-3 weeks after drug exposure
  • Most commonly due to cefaclor (1 in 2000 children)
  • Other associated drugs: penicillins, NSAIDs, phenytoin, sulfonamides, minocycline, propranolol

Mx: STOP drug, NSAIDs, antihistamines ?prednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HEREDITARY ANGIOEDEMA

A

Recurrent angioedema without wheals

Pathophysiology:

Types I & II: inadequate levels of functioning C1 inh - > excessive production of bradykinin -> inflammation with leakage of fluid through vessel walls –> oedema

Type III: (20% cases) mutation causes production of Factor XII which has increased activity. –> increased production of bradykininàoedema

Treatment:
• C1 inhibitor

• Icatibant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Congenital melanocytic Naevi

A

Size (projected adult size):

  • Small:<1.5cmdiameter
  • Medium:1.5-20cmdiameter
  • Large/giant:>20cmdiameter

Giant CMN:
• 70%satellitenaevi
• 5-10% neurocutaneous melanosis

• MRI brain/spine(ideally<6/12age)

  • Benign proliferative nodules common
  • Increased risk of melanoma (CNS or skin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Erythema toxicum neonatorum

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Congenital pustular melanosis

A

Onset: birth

Clinical features: pustules without erythema -> collarettes of scale –> hyperpigmented macules (persist

for months). Skin changes can occur any region, including palms/soles

More common in infants of African descent

Diagnostic studies: Wright’s stain:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neonatal cephalic pustulosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Genes in eczematous conditions

  • Atopic dermatitis
  • Netherons
  • Wiskot aldrich
  • Hyper IgE
  • XL icthyosis
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dermatoses

  • TS
  • NF
  • Ataxia telangiectasia
  • EB
A